Evidence Hub

First report of sporotrichosis by Sporothrix brunneoviolacea

Rodrgiues Trápaga M, Spruijtenburg B, Jacomel B, Hidalgo JED, Sanchotene KO, Bernardon FF, Esperon BM, Poester VR et al.

Medical mycology case reports, 2025

Abstract

Sporotrichosis is a neglected fungal disease, affecting mammals. Here, a feline patient presented a small ulcerated lesion. Short treatment by itraconazole resulted in clinical cure. The isolate was identified as Sporothrix brunneoviolacea by sequencing. Despite proper growth, antifungal susceptibility testing by microbroth dilution could not be performed due to a lack of growth. This is the first report of sporotrichosis by S. brunneoviolacea, which was originally classified as an environmental and non-pathogenic species.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free